Dermorphin 2mg – 10 vials

Dermorphin is a naturally occurring heptapeptide first isolated from the skin of the South American frog Phyllomedusa sauvagei. It is widely regarded as one of the most potent endogenous opioid peptides identified to date, exhibiting a binding affinity for mu-opioid receptors (MOR) estimated to be 30–40 times greater than that of morphine on a molar basis. Its unusual D-amino acid configuration at position 2 (D-Ala) confers exceptional resistance to enzymatic degradation, making it a valuable research tool for studying opioid receptor pharmacology and ligand–receptor interactions.

In preclinical research settings, dermorphin has been employed to investigate analgesic signalling pathways, opioid receptor selectivity, and the neurobiological mechanisms underpinning pain modulation. It has also served as a scaffold for the development of novel opioid-based therapeutic candidates and receptor-selective analogues.

Each vial of Peptician’s Dermorphin contains 2mg of lyophilised peptide with a purity exceeding 98% as verified by HPLC analysis. Molecular formula: C₄₀H₅₁N₇O₁₀; molecular weight: 801.9 g/mol; CAS number: 77614-16-5. Reconstitute with sterile bacteriostatic water or an appropriate solvent prior to use. Store lyophilised product at −20°C, protected from light and moisture.

For research purposes only. Not for human use.